With Johnson & Johnson Deals, Berkeley's Aduro Biotech Gets New Chance To Prove Worth
Published: Jun 18, 2014
The idea behind Aduro BioTech’s experimental cancer treatment—turning a dangerous food-borne bacterium into a Trojan horse against tumors—may seem startlingly new. But the project arose a dozen years ago, and incubated slowly in three different companies, before emerging this summer into a long-awaited splash of sunlight.
Hey, check out all the research scientist jobs. Post your resume today!